News

Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.
Once considered obscure or opportunistic, invasive fungal infections are now surfacing with alarming frequency - and in ...
Experts warn that Candida auris, a fungus that can be life-threatening to sick individuals, is spreading at a rapid rate in U ...
To combat long-overlooked fungal pathogens, researchers and regulators must embrace innovative science and policy.
Others turn to oral antifungal drugs that come with a risk of liver damage and other side effects. Unfortunately, most of these approaches fail to eliminate the fungus at its root, especially when ...
Crop spraying in the United States could make a £250 million antifungal drug ineffective before it even reaches the market, ...
Cases of Candida auris, a dangerous, drug-resistant fungus, are rising in hospitals and senior care centers across the U.S.
More innovative research and development (R&D) is needed to address lack of medicines and diagnostic tools for invasive fungal diseases, the World Health Organization has said.In a statement, Dr ...